![Logo_metalyse Logo_metalyse](/no/sites/default/files/2024-02/Logo_metalyse.png)
Time is Brain
Metalyse 25 mg is now available for adults for thrombolytic treatment of acute ischaemic stroke within 4.5 hours from last known well and after exclusion of intracranial haemorrhage1
Because Every
Minute Matters
![Hero-Primary](/no/sites/default/files/2024-02/Hero-Primary.jpg)
Stroke affects more than 12 million people each year. It is the second leading cause of death worldwide. Unfortunately, this number is only expected to rise because of an ageing global population.2
Acute ischaemic stroke (AIS) occurs when a vessel supplying blood to the brain is obstructed, depriving brain tissue of oxygen and nutrients. If blood flow is not restored fast enough, damage to brain cells in a particular area can lead to permanent disability and even death3-5. That’s why when it comes to stroke, every minute matters.
![Metalyze_Photo_4 Metalyze_Photo_4](/no/sites/default/files/2024-02/Metalyze_Photo_4.png)
![Time is Brain Time is Brain](/no/sites/default/files/2024-04/Time%20is%20Brain%20Page.png)
Time is Brain
References
-
Metalyse® European Summary of Product Characteristics. (12/2023)
-
World Stroke Organization, https://www.world-stroke.org/world-stroke-day-campaign/about-stroke/impact-of-stroke.
-
Donkor ES. Stroke Res Treat. 2018; 3238165.
-
Meretoja et al, Stroke. 2018.
-
Saver JL. Stroke 2006; 37:263-266.